|More News >>|
Most people may not consider Purdue University when they think of drug discovery. "Neither did we," admits Purdue chemist Phil Low, whose discoveries helped form West Lafayette-based cancer drug company Endocyte. He says the university didn't realize its own strength until it formally counted the number of drugs it had in human clinical trials. Purdue leaders were surprised to find the sum rivals the most prominent universities and medical schools in the country. The realization has led to what Purdue drug research may need most: a dose of self-promotion in the form of a new $25 million Drug Discovery Building.
Research at the undergraduate level is key to generating the highly skilled workforce that will foster the growth of Indiana's technology-driven economy.
Inside INdiana Business, BioCrossroads and Indiana University have launched a new partnership to communicate the growth, success and excitement surrounding Indiana's life sciences industry. We share a belief that this innovative field plays a vital role in the development of the entrepreneurs, innovations and businesses that will allow Indiana to compete in a global economy. Life Sciences INdiana is published by the special projects unit of Grow INdiana Media Ventures LLC, the parent company of the Inside INdiana Business brand of business news products.
To submit a story or ask a question, please contact
The video and audio excerpts are licensed for private, non-commercial use only. Any other use is strictly prohibited without the expressed, written permission of Grow Indiana Media Ventures, LLC. Duplication in whole or part of the video or audio contained within is strictly prohibited. All other rights reserved.